-
Product Name
FRS2 antibody
- Documents
-
Description
FRS2 Rabbit Polyclonal antibody. Positive IHC detected in human prostate cancer tissue. Positive IF detected in MCF-7 cells. Positive WB detected in MCF-7 cells, human brain tissue, NIH/3T3 cells. Observed molecular weight by Western-blot: 68 kDa
-
Tested applications
ELISA, IHC, WB, IF
-
Species reactivity
Human,Mouse,Rat; other species not tested.
-
Alternative names
FGFR signaling adaptor SNT antibody; FGFR substrate 2 antibody; FRS2 antibody; FRS2A antibody; FRS2alpha antibody; SNT antibody; SNT 1 antibody; SNT1 antibody
-
Isotype
Rabbit IgG
-
Preparation
This antibody was obtained by immunization of FRS2 recombinant protein (Accession Number: NM_006654). Purification method: Antigen affinity purified.
-
Clonality
Polyclonal
-
Formulation
PBS with 0.1% sodium azide and 50% glycerol pH 7.3.
-
Storage instructions
Store at -20℃. DO NOT ALIQUOT
-
Applications
Recommended Dilution:
WB: 1:500-1:5000
IHC: 1:20-1:200
IF: 1:10-1:100
-
Validations
Immunohistochemical of paraffin-embedded human prostate cancer using Catalog No:110777(FRS2 antibody) at dilution of 1:50 (under 10x lens)
MCF-7 cells were subjected to SDS PAGE followed by western blot with Catalog No:110777(FRS2 Antibody) at dilution of 1:1000
Immunofluorescent analysis of MCF-7 cells using Catalog No:110777(FRS2 Antibody) at dilution of 1:25 and Alexa Fluor 488-congugated AffiniPure Goat Anti-Rabbit IgG(H+L)
-
Background
Fibroblast growth factor (FGF) receptor substrate 2 (FRS2) has an alternative name as SNT-1, it is an adapter protein that links activated FGR and NGF receptors to downstream signaling pathways. FGF receptor substrates (FRS2 and FRS3) are key adaptor proteins that mediate FGF-FGFR signalling in benign as well as malignant tissue. FRS2 is a 508 amino-acid protein,which is phosphorylated on tyrosine residues. The molecular weight of non-phosphorylated FRS2 is 57-68 kDa, but phosphorylated FRS2 is 80-90 kDa. Phosphorylation of FRS2 is associated with activation of a number of MAP kinases. Allele-specific regulation of FGFR2 mRNA expression with a mildly increased breast cancer risk has been reported.
-
References
- Wang X, Asmann YW, Erickson-Johnson MR. High-resolution genomic mapping reveals consistent amplification of the fibroblast growth factor receptor substrate 2 gene in well-differentiated and dedifferentiated liposarcoma. Genes, chromosomes & cancer. 50(11):849-58. 2011.
- Zhang K, Chu K, Wu X. Amplification of FRS2 and activation of FGFR/FRS2 signaling pathway in high-grade liposarcoma. Cancer research. 73(4):1298-307. 2013.
Related Products / Services
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"